ARCHIVES

Duke, M.D. Anderson Receive Bristol-Myers Unrestricted Grants

This article is from The Cancer Letter archive.

Vol. 15 No. 18 | May 5, 1989

Download PDF Visit The Full Archive

Related Articles

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

Sandra Swain Is Acting Chief Of NCI’s Medicine Branch.

July 21, 2000

‘Dear Dr. Bick’: Letters Reflect Turmoil Over Conflict Of Interest

January 26, 1990

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

U.S., France Offer Carcinogenesis Program

February 13, 1981

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014